Site icon OncologyTube

Evaluating the Risk for Progression in MPNs

Will my essential thrombocythemia (ET) or polycythemia vera (PV) progress to myelofibrosis (MF)? Patient Power host and MF patient, Andrew Schorr, asks MPN expert Dr. Mark Heaney of Columbia University Medical Center questions regarding the connection between ET and PV and their potential progression to MF. Dr. Heaney explains why ongoing serial follow-ups remain important even though MPN progression does not always occur.

Get email alerts | http://www.patientpower.info/alerts

Subscribe on YouTube | http://www.youtube.com/patientpower
Like on Facebook | http://www.fb.com/patientpower.info
Follow on Twitter | http://www.twitter.com/patientpower
Follow on Google+ | http://www.google.com/+patientpowerinfo

Advertisement
Exit mobile version